Day: February 20, 2025

Hudson Technologies to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Results

Written by Customer Service on February 20, 2025. Posted in Public Companies.

WOODCLIFF LAKE, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Thursday, March 6, 2025 at 5:00 p.m. Eastern Time to discuss the Company’s fourth quarter and full year 2024 results. Please visit this link at least 5 minutes prior to the scheduled start time in order to register and receive dial-in and webcast details. A replay of the teleconference will be available until April 5, 2025, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 52007. About Hudson Technologies Hudson Technologies, Inc. is a leading provider of innovative and sustainable refrigerant products and services to the Heating Ventilation Air Conditioning and Refrigeration industry. For nearly three decades,...

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

Written by Customer Service on February 20, 2025. Posted in Public Companies.

– Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions – – Reflects positive preliminary Phase 2 Safety and Efficacy data reported to date – – May also lead to Priority Review and Accelerated Biologics License Application (“BLA”) Approval for BRTX-100 – MELVILLE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”). “We are thrilled that the FDA has granted Fast Track designation, underscoring the potential of BRTX-100 to fill significant...

KULR Achieves AS9100 Certification

Written by Customer Service on February 20, 2025. Posted in Public Companies.

Certification will Strengthen KULR’s Position in Aerospace and Defense Manufacturing Sector HOUSTON, Feb. 20, 2025 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leader in advanced energy management platforms, today announced their Webster, Texas headquarters facility has achieved AS9100 certification. This certification is a significant milestone confirming KULR’s commitment to quality, safety, and customer satisfaction within the aerospace and defense manufacturing sectors. “The AS9100 certification reflects KULR’s dedication to producing the highest-quality products within the aerospace and defense industries,” said KULR Chief Technology Officer Will Walker. “With customer satisfaction at the forefront, we will continue to manufacture custom and commercial-off-the-shelf...

Independent Proxy Advisory Firms Recommend Quisitive Shareholders Vote for the Proposed Acquisition by H.I.G. Capital

Written by Customer Service on February 20, 2025. Posted in Mergers And Acquisitions.

TORONTO, Feb. 20, 2025 (GLOBE NEWSWIRE) — Quisitive Technology Solutions, Inc. (“Quisitive” or the “Company”) (TSXV: QUIS; OTCQX: QUISF) is pleased to announce that two leading independent proxy advisory firms, including Institutional Shareholder Services Inc. (“ISS”), have recommended that holders (the “Shareholders”) of common shares of Quisitive (the “Shares”) vote “FOR” the resolution approving the proposed acquisition of Quisitive by an affiliate of funds managed by H.I.G. Capital, LLC pursuant to a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). The ISS report states that, among other things, “the offer represents a meaningful premium to the unaffected price, the special committee appears to have run a robust process…As such, support for the proposal is warranted.” The ISS report...

Where Food Comes From, Inc. Reports 2024 Fourth Quarter and Full Year Financial Results

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

Fourth Quarter Highlights – 2024 vs. 2023Verification and certification revenue: $5.4M vs. $5.5MProduct sales: $922,000 vs. $871,000Total revenue flat at $6.7MNet income: $961,000 vs. $776,000Diluted EPS: $0.18 vs. $0.14Stock buybacks: 57,018 sharesFull Year Highlights – 2024 vs. 2023Verification and certification revenue: $20.6M vs. $19.4MProduct sales: $3.8M vs. $4.0Total revenue: $25.7M vs. $25.1MNet income: $2.1M vs. $2.2MDiluted EPS: $0.40 vs. $0.39Cash generated from operations: $2.7M vs. $2.8MCash & cash equivalents: $2.0 million vs. $2.6 million at 2023 year-endStock buybacks and private repurchases: 273,057 sharesTotal buybacks since plan inception plus private purchases: 1,191,636 shares at purchase price of $13.0 million, or approximately $10.92 per shareTotal value returned...

Greystone Housing Impact Investors Reports Fourth Quarter 2024 and Annual 2024 Financial Results

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

OMAHA, Neb., Feb. 20, 2025 (GLOBE NEWSWIRE) — On February 20, 2025, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months and year ended December 31, 2024. Financial Highlights The Partnership reported the following results as of and for the three months ended December 31, 2024:Net income of $0.39 per Beneficial Unit Certificate (“BUC”), basic and diluted Cash Available for Distribution (“CAD”) of $0.18 per BUC Total assets of $1.58 billion Total Mortgage Revenue Bond (“MRB”) and Governmental Issuer Loan (“GIL”) investments of $1.25 billionThe difference between reported net income per BUC and CAD per BUC is primarily due to the treatment of unrealized gains on the Partnership’s interest rate derivative positions. Unrealized gains of approximately $7.0 million...

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

Company achieved significant commercial progress in 2024, finishing with total revenue of $333.6 million, including $319.2 million in U.S. Net Product Sales Company reaffirms combined peak sales of IBSRELA and XPHOZAH of $1.75 Billion Company ended FY 2024 with $250.1 million in cash, cash equivalents and investments Conference call scheduled for 8:00 AM Eastern Time WALTHAM, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided a business update. “Ardelyx enters 2025 in a position of strength, evidenced by significant year-over-year revenue...

FTI Consulting Reports Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

Fourth Quarter 2024 Revenues of $894.9 Million, Down 3% Compared to $924.7 Million in Prior Year Quarter Fourth Quarter 2024 EPS of $1.38 and Adjusted EPS of $1.56, Compared to EPS and Adjusted EPS of $2.28 in Prior Year Quarter Record Full Year 2024 Revenues of $3.699 Billion, Up 6% Compared to $3.489 Billion in Prior Year Record Full Year 2024 EPS of $7.81 and Adjusted EPS of $7.99, Compared to EPS and Adjusted EPS of $7.71 in Prior Year Introduces 2025 GuidanceWASHINGTON, Feb. 20, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released financial results for the full year and fourth quarter ended December 31, 2024. For the full year 2024, revenues of $3.699 billion increased $209.4 million, or 6.0%, compared to revenues of $3.489 billion in the prior year. The increase in revenues was driven by revenue growth...

Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2024

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

Total revenue was €50.0 mm in Q4 2024, while net gaming revenue1 was €52.6 mm in the period, 5% above Q4 2023. Net income excluding the non-cash variation in fair value of public warrants2 was €6.8 mm in 2024 versus a net loss of €4.0 mm in 2023. Total cash position of €40.5 mm as of December 31, 2024. Providing full year 2025 net gaming revenue outlook of €220-230 mm and Adj. EBITDA3 outlook of €10-15 mm. The Company’s Board of Directors has authorized a share buyback plan of up to $5.0 mm, subject to shareholder approval.Madrid, Spain and Tel Aviv, Israel, February 20, 2025 – (GLOBE NEWSWIRE) Codere Online (Nasdaq: CDRO / CDROW, the “Company”), a leading online gaming operator in Spain and Latin America, has released its preliminary unaudited4 financial results for the quarter and year ended December 31, 2024. Below are the main...

BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update

Written by Customer Service on February 20, 2025. Posted in Earnings Releases And Operating Results.

– As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval – Attruby (acoramidis), the first and only near-complete TTR stabilizer (≥90%) was approved by the FDA to reduce cardiovascular death and cardiovascular-related hospitalization in ATTR-CM patients on November 22, 2024 – Acoramidis was approved as BEYONTTRA™ in the EU on February 10, 2025, achieving a $75 million milestone payment and ongoing royalties in a tiered structure beginning in the low-thirties percent on sales in the EU – Acoramidis demonstrated a 59% hazard reduction on the composite endpoint of all-cause mortality and first cardiovascular-related hospitalization in the variant ATTR-CM population by month 30; to the Company’s knowledge, this benefit...

Day: February 20, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals